1. A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon.
- Author
-
Otrock ZK, Chamseddine N, Salem ZM, Wehbe T, Al-Ayoubi M, Dhaini M, Kattan J, Mokaddem W, Nasr TA, Jradi O, Farhat FS, Wehbe M, Haidar MH, Kharfan-Dabaja MA, Bitar N, Hajj ME, Kadri AM, Kamar FG, Yassine H, Khodr H, Taher AT, Hakime N, Mahfouz RA, Serhal W, Bazarbachi A, and Farhat HZ
- Abstract
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders characterized by peripheral blood cytopenias, blood cells dysplasia, and increased risk for progression to acute leukemia.Physicians should be vigilant in diagnosing MDS and should be aware of the contemporary therapies that are always in progress. Most of the data on MDS epidemiology and management comes from developed countries. The incidence and features of MDS in the Arab countries, among them Lebanon, are not known. We undertook a nationwide epidemiological registry study of all newly diagnosed MDS cases through 2010-2011. Patients were referred by 21 hematologists/oncologists practicing in 17 hospitals and medical centers distributed across the entire country. 58 patients (29 males and 29 females) with confirmed MDS were included. The calculated incidence rate of MDS was 0.71 per 100,000 people. The median age at diagnosis was 73 years (range 16-86). The most common complaints on presentation were fatigue (70.7%), weakness (60.3%) and pallor (43.1%). Most patients were diagnosed as refractory anemia with excess blasts (RAEB; 36.2%) and refractory cytopenia with multilineage dysplasia (RCMD; 32.8%). This paper constitutes the first epidemiological report on the incidence and specific subtypes of MDS in Lebanon.
- Published
- 2015